A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans

Infection and Immunity

Volumn 79, Issue 6, 2011, Pages 2193-2203

  Qi, Manli ^a,b   Gong, Siqi ^a   Lei, Lei ^a   Liu, Quanzhong ^b   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DODECYL SULFATE SODIUM; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN B; PROTEINASE; SAPONIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CYTOPLASM; CYTOSOL; FEMALE; HOST CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; PRIORITY JOURNAL; SERUM;

ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS;

EID: 79959369008     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00003-11     Document Type: Article

References (68)

1. Allen, J. E., and R. S. Stephens. 1989. Identification by sequence analysis of two-site posttranslational processing of the cysteine-rich outer membrane protein 2 of Chlamydia trachomatis serovar L2. J. Bacteriol. 171:285-291.
2. Bas, S., P. Muzzin, and T. L. Vischer. 2001. Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens. J. Clin. Microbiol. 39:4082-4085.
3. Batteiger, B. E., W. J. V, Newhall 5th, and R. B. Jones. 1985. Differences in outer membrane proteins of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis. Infect. Immun. 50:488-494.
4. Belland, R. J., et al. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. U. S. A. 100:8478-8483.
5. Betts-Hampikian, H., and K. Fields. 2010. The chlamydial type III secretion mechanism: revealing cracks in a tough nut. Front. Microbiol. 1:13.
6. Centers for Disease Control and Prevention. November 2009. Sexually transmitted disease surveillance, 2008. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/std/stats08/toc.htm.
7. Chen, C., et al. 2006. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect. Immun. 74:4826-4840.
8. Chen, D., et al. 2010. Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway. Microbiology 156:3031-3040.
9. Chen, D., et al. 2010. Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. J. Bacteriol. 192:6017-6024.
10. Chen, D. J., et al. 2010. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl. Acad. Sci. U. S. A. 107:3099-3104.
11. Chen, J. C., and R. S. Stephens. 1997. Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells. Microb. Pathog. 22:23-30.
12. Curran, J. W. 1980. Economic consequences of pelvic inflammatory disease in the United States. Am. J. Obstet Gynecol. 138:848-851.
13. Dong, F., M. Pirbhai, Y. Zhong, and G. Zhong. 2004. Cleavage-dependent activation of a chlamydia-secreted protease. Mol. Microbiol. 52:1487-1494.
14. Dong, F., J. Sharma, Y. Xiao, Y. Zhong, and G. Zhong. 2004. Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors. Infect. Immun. 72:3869-3875.
15. Eko, F. O., et al. 2004. A novel recombinant multisubunit vaccine against Chlamydia. J. Immunol. 173:3375-3382.
16. Everett, K. D., and T. P. Hatch. 1995. Architecture of the cell envelope of Chlamydia psittaci 6BC. J. Bacteriol. 177:877-882.
17. Fadel, S., and A. Eley. 2007. Chlamydia trachomatis OmcB protein is a surface-exposed glycosaminoglycan-dependent adhesin. J. Med. Microbiol. 56:15-22.
18. Fadel, S., and A. Eley. 2008. Differential glycosaminoglycan binding of Chlamydia trachomatis OmcB protein from serovars E and LGV. J. Med. Microbiol. 57:1058-1061.
19. Fan, T., et al. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187:487-496.
20. Fortunati, E., and V. Bianchi. 1989. Plasma membrane damage detected by nucleic acid leakage. Mol. Toxicol. 2:27-38.
21. Frikha-Gargouri, O., et al. 2008. Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections. BMC Microbiol. 8:217.
22. Germain, R. N. 1995. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines. Ann. N. Y. Acad. Sci. 754:114-125.
23. Gervassi, A. L., et al. 2004. Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis. J. Immunol. 173:6905-6913.
24. Giles, D. K., J. D. Whittimore, R. W. LaRue, J. E. Raulston, and P. B. Wyrick. 2006. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. Microbes Infect. 8:1579-1591.
25. Goodall, J. C., G. Yeo, M. Huang, R. Raggiaschi, and J. S. Gaston. 2001. Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library. Eur. J. Immunol. 31:1513-1522.
26. Grayston, J. T., S. P. Wang, R. L. Woolridge, and E. R. Alexander. 1964. Prevention of trachoma with vaccine Arch. Environ. Health 8:518-526.
27. Grayston, J. T., R. L. Woolridge, and S. Wang. 1962. Trachoma vaccine studies on Taiwan. Ann. N. Y. Acad. Sci. 98:352-367.
28. Hackstadt, T., M. A. Scidmore-Carlson, E. I. Shaw, and E. R. Fischer. 1999. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell. Microbiol. 1:119-130.
29. Huang, Z., et al. 2008. Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe 4:529-542.
30. Jamur, M. C., and C. Oliver. 2010. Permeabilization of cell membranes. Methods Mol. Biol. 588:63-66.
31. Johnson, J. A., M. O. Gray, J. S. Karliner, C. H. Chen, and D. Mochly-Rosen. 1996. An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research. Circ. Res. 79:1086-1099.
32. Jorgensen, I., and R. H. Valdivia. 2008. Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusion. Infect. Immun. 76:3940-3950.
33. Kim, J. Y., et al. 2008. Engineered bacterial outer membrane vesicles with enhanced functionality. J. Mol. Biol. 380:51-66.
34. Land, J. A., J. E. Van Bergen, S. A. Morre, and M. J. Postma. 2010. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum. Reprod. Update 16:189-204.
35. Li, Z., et al. 2008. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect. Immun. 76:2746-2757.
36. Li, Z., D. Chen, Y. Zhong, S. Wang, and G. Zhong. 2008. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydiainfected cells. Infect. Immun. 76:3415-3428.
37. Li, Z., et al. 2008. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol. 8:90.
38. Liu, X., M. Afrane, D. E. Clemmer, G. Zhong, and D. E. Nelson. 2010. Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics. J. Bacteriol. 192:2852-2860.
39. Matsumoto, A., and G. P. Manire. 1970. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 101:278-285.
40. Melgosa, M. P., C. C. Kuo, and L. A. Campbell. 1993. Outer membrane complex proteins of Chlamydia pneumoniae. FEMS Microbiol. Lett. 112: 199-204.
41. Moelleken, K., and J. H. Hegemann. 2008. The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding. Mol. Microbiol. 67:403-419.
42. Morrison, R. P., and H. D. Caldwell. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751.
43. Morrison, R. P., K. Feilzer, and D. B. Tumas. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4661-4668.
44. Morrison, S. G., and R. P. Morrison. 2005. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175:7536-7542.
45. Mygind, P., G. Christiansen, and S. Birkelund. 1998. Topological analysis of Chlamydia trachomatis L2 outer membrane protein 2. J. Bacteriol. 180: 5784-5787.
46. Mygind, P., G. Christiansen, K. Persson, and S. Birkelund. 1998. Analysis of the humoral immune response to Chlamydia outer membrane protein 2. Clin. Diagn. Lab. Immunol. 5:313-318.
47. Naglak, T. J., D. J. Hettwer, and H. Y. Wang. 1990. Chemical permeabilization of cells for intracellular product release. Bioprocess Technol. 9:177-205.
48. Newhall, W. J., V. 1987. Biosynthesis and disulfide cross-linking of outer membrane components during the growth cycle of Chlamydia trachomatis. Infect. Immun. 55:162-168.
49. Olsen, A. W., M. Theisen, D. Christensen, F. Follmann, and P. Andersen. 2010. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model. PLoS One 5:e10768.
50. Penttila, T., et al. 2004. DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. Vaccine 22:3386-3394.
51. Pultorak, E., W. Wong, C. Rabins, and S. D. Mehta. 2009. Economic burden of sexually transmitted infections: incidence and direct medical cost of Chlamydia, gonorrhea, and syphilis among Illinois adolescents and young adults, 2005-2006. Sex. Transm. Dis. 36:629-636.
52. Rockey, D. D., J. Wang, L. Lei, and G. Zhong. 2009. Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev. Vaccines 8:1365-1377.
53. Saren, A., et al. 2002. Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect. Immun. 70:3336-3343.
54. Sharma, J., A. M. Bosnic, J. M. Piper, and G. Zhong. 2004. Human antibody responses to a Chlamydia-secreted protease factor. Infect. Immun. 72:7164-7171.
55. Sharma, J., et al. 2006. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 74:1490-1499.
56. Stephens, R. S., K. Koshiyama, E. Lewis, and A. Kubo. 2001. Heparinbinding outer membrane protein of chlamydiae. Mol. Microbiol. 40:691-699.
57. Telyatnikova, N., and J. S. Hill Gaston. 2006. Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis. FEMS Immunol. Med. Microbiol. 47:190-198.
58. Valdivia, R. H. 2008. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr. Opin. Microbiol. 11:53-59.
59. Wagels, G., S. Rasmussen, and P. Timms. 1994. Comparison of Chlamydia pneumoniae isolates by Western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. J. Clin. Microbiol. 32:2820-2823.
60. Wang, J., et al. 2010. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. 185:1670-1680.
61. Watson, M. W., P. R. Lambden, J. S. Everson, and I. N. Clarke. 1994. Immunoreactivity of the 60 kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli. Microbiology 140:2003-2011.
62. Wizel, B., et al. 2002. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J. Immunol. 169:2524-2535.
63. Zhang, J. P., and R. S. Stephens. 1992. Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 69:861-869.
64. Zhong, G. 2009. Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol. 17:467-474.
65. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.
66. Zhong, G., L. G. S. Lei, C. Lu, M. Qi, and D. Chen. 2011. Chlamydia-secreted proteins in chlamydial interactions with host cells. Curr. Chem. Biol. 5:9.
67. Zhong, G., L. Liu, T. Fan, P. Fan, and H. Ji. 2000. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J. Exp. Med. 191:1525-1534.
68. Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. U. S. A. 94:13856-13861.